Outlook Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
111 Wood Ave S Unit 100, Iselin, New Jer...Phone Number
(609) 619-3990Website
www.outlooktherapeutics.comRevenue
-Stock Symbol
OTLKIndustry
About Outlook Therapeutics
Outlook Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative ophthalmic therapies for retinal diseases. The company specializes in advancing treatments designed to preserve vision and improve outcomes for patients with conditions such as wet age-related macular degeneration and other serious retinal disorders. Through its expertise in biologics, clinical development, and ophthalmology, Outlook Therapeutics aims to deliver high-quality, clinically validated therapies that address unmet needs in retinal care while enhancing accessibility, treatment consistency, and long-term eye health for patients worldwide.Explore more
Outlook Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Outlook Therapeutics
Compare insights from companies similar to Outlook Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Outlook Therapeutics Tech Stack
A closer look at the technologies used by Outlook Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Outlook Therapeutics
Sign Up For FreeTo access detailed company insights
Outlook Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative ophthalmic therapies for retinal diseases. The company specializes in advancing treatments designed to preserve vision and improve outcomes for patients with conditions such as wet age-related macular degeneration and other serious retinal disor... Read More
